
Journal of Medicinal Chemistry p. 516 - 521 (1983)
Update date:2022-08-05
Topics:
Neumeyer, John L.
Reischig, Dirk
Arana, George W.
Campbell, Alexander
Baldessarini, Ross J.
et al.
The enantiomers <(S)-(+) and (R)-(-)> of N-n-propylnorapomorphine (NPA) were synthesized. (R)-NPA was obtained by the acid-catalyzed rearrangement of N-n-propylnormorphine. (R)-NPA also was converted to (RS)-N-n-propylnorapomorphine dimethyl ether by dehydrogenation of the 10,11-O,O'-dimethyl ether of (R)-NPA with 10percent palladium on carbon in acetonitrile, followed by reduction with sodium cyanoborohydride under acidic conditions.Alternatively (RS)-NPA 10,11-O,O'-dimethyl ether was obtained via total synthesis. (+)-Dibenzoyl-D-tartaric acid was used to resolve (RS)-NPA dimethyl ether.Ether cleavage gave (S)-NPA isolated as the hydrochloride salt in greater than 99.9percent enantiomeric purity, as determined by circular dichroism (CD) spectra.The pharmacological activities of (S)- and (R)-NPA were evaluated with subnanomolar concentrations of 3H-labeled apomorphine (APO), ADTN, and spiroperidol (SPR) for competition for binding to a membrane-rich subsynaptosomal fraction of calf caudate nucleus.IC50 (nM) values for (R)-NPA vs. (S)-NPA were as follows: <3>APO, 2.5 vs. 66; <3>ADTN, 2.0 vs. 60; <3>SPR, 174 vs. 1400.The efficacy of (R)- and (S)-NPA in stimulating dopamine-sensitive adenylate cyclase from both homogenates of rat corpus striatum and pieces of intact carp retina was also evaluated.Three behavioral effects in the rat (stereotyped behavior, sedation, and catalepsy) were also examined.Only (R)-NPA induced stereotypy; (S)-NPA failed to antagonize this action of the R isomer.The effects of (R)- and (S)-NPA on adenylate cyclase agreed with the behavioral effects and radioreceptor binding assays in that the R isomer was the strongly preferred enantiomer at dopamine receptors.The S enantiomer of NPA was, however, the weakly preferred configuration for rat liver catechol O-methyltransferase.A dopamine-receptor model accommodates the configuration of NPA and related aporphines
View MoreShanghai Norky Pharmaceutical Co., LTD.
website:http://www.norkypharm.com
Contact:86-21-61075300
Address:1165 Jiangning Road, Office 1502, Shanghai, China
Beijing Mashi Fine Chemical Co.,Ltd.
Contact:+86-10-61271592
Address:Room 506, Section B, Kaichi Mansion, Industrial Development
Melone Pharmaceutical Co., ltd
Contact:+86-411 82593920, 82593631
Address:No 232, JInma Roda, Development Zone, Dalian, China
Ningbo Inno Pharmchem Co., Ltd.
Contact:86-574-87319282
Address:6F-5,NO.163 RUIQING RD.,NINGBO 315000 CHINA
Hubei Lansun Biochemical Pharmaceutical Co., Ltd
Contact:714-6395977
Address:No. 81 Pengcheng Avenue, economic and technological development zone, Huangshi City, Hubei Province,China
Doi:10.1039/b413724h
(2005)Doi:10.1016/j.bmcl.2018.03.051
(2018)Doi:10.1002/ejoc.200400630
(2005)Doi:10.1248/cpb.56.176
(2008)Doi:10.1016/j.jorganchem.2004.08.047
(2005)Doi:10.1021/jo00158a025
(1983)